Literature DB >> 14586053

Lymphangioleiomyomatosis: a case-control study of perinatal and early life events.

C I Whale1, S R Johnson, K G Phillips, S A Newton, S A Lewis, A E Tattersfield.   

Abstract

BACKGROUND: Lymphangioleiomyomatosis (LAM), a rare disease affecting women, is caused by somatic mutations in the tuberous sclerosis complex genes.
METHODS: A case-control questionnaire study was carried out examining parental and family history, prenatal events, and early life events to try to shed light on the aetiology of the condition. Forty five patients identified from a national LAM register completed a questionnaire and 31 were compared with 117 age and sex matched control subjects using conditional logistic regression.
RESULTS: No differences were found in perinatal events, childhood infections, and parental or family history, except that patients were more likely to be an only child (odds ratio (OR) 4.3 (95% confidence interval (CI), 1.5 to 11.8)) and have a relative with uterine fibroids (OR 4.2 (1.4 to 13)). Patients with LAM had had fewer pregnancies and fewer children but no differences in miscarriage rates. A non-matched analysis using all 45 cases and 117 controls gave similar results.
CONCLUSIONS: No features in the family history, perinatal events, or early life events were detected that were associated with having LAM. Being more likely to be an only child and having an increased family history of uterine fibroids may, if confirmed, indicate some differences in reproductive function within the families of affected individuals.

Entities:  

Mesh:

Year:  2003        PMID: 14586053      PMCID: PMC1746512          DOI: 10.1136/thorax.58.11.979

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  16 in total

1.  Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis.

Authors:  N M Byrne; P M Keavey; J D Perry; F K Gould; D A Spencer
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

2.  Pulmonary lymphangiomyomatosis. A review.

Authors:  B Corrin; A A Liebow; P J Friedman
Journal:  Am J Pathol       Date:  1975-05       Impact factor: 4.307

3.  Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Authors:  T Carsillo; A Astrinidis; E P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.

Authors:  Teruhiko Sato; Kuniaki Seyama; Hiroaki Fujii; Hiroshi Maruyama; Yasuhiro Setoguchi; Shin-ichiro Iwakami; Yoshinosuke Fukuchi; Okio Hino
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

5.  How many controls?

Authors:  M Gail; R Williams; D P Byar; C Brown
Journal:  J Chronic Dis       Date:  1976-11

6.  Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment.

Authors:  S R Johnson; A E Tattersfield
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

7.  Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis.

Authors:  D N Franz; A Brody; C Meyer; J Leonard; G Chuck; S Dabora; G Sethuraman; T V Colby; D J Kwiatkowski; F X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

8.  Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment.

Authors:  S Yano
Journal:  Thorax       Date:  2002-12       Impact factor: 9.139

9.  Clinical experience of lymphangioleiomyomatosis in the UK.

Authors:  S R Johnson; A E Tattersfield
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

10.  Pulmonary lymphangioleiomyomatosis (LAM): examining oral contraceptive pills and the onset of disease.

Authors:  Elana M Oberstein; Lora E Fleming; Orlando Gómez-Marin; Marilyn K Glassberg
Journal:  J Womens Health (Larchmt)       Date:  2003 Jan-Feb       Impact factor: 2.681

View more
  1 in total

1.  Survival and disease progression in UK patients with lymphangioleiomyomatosis.

Authors:  S R Johnson; C I Whale; R B Hubbard; S A Lewis; A E Tattersfield
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.